Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction

Summary

This project proposes to implement and compare new community pharmacy-based strategies for improving vaccine coverage.

Conditions

• Healthy

Interventions

BIOLOGICAL

Meningococcal B

Bexsero is indicated for active immunisation of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B.

BIOLOGICAL

High-Dose TIV

Fluzone High-Dose is an injectable influenza vaccine made to protect against the flu strains most likely to cause illness for that particular flu season.

BIOLOGICAL

Tdap (tetanus-diphtheria-acellular pertussis)

Tdap is a combination vaccine that protects against three potentially life-threatening bacterial diseases: tetanus, diphtheria, and pertussis (whooping cough).

BIOLOGICAL

Meningococcal ACWY

Meningococcal ACWY vaccine is indicated for active immunization of individuals up to 55 years of age against invasive meningococcal diseases caused by Neisseria meningitides serogroups A, C, W-135 and Y.

BIOLOGICAL

Herpes Zoster

Herpes zoster vaccine is indicated for the immunization of individuals 50 years of age or older for the prevention of herpes zoster (shingles).

BIOLOGICAL

Travel Health (Hepatitis A, Hepatitis B, Typhoid Fever)

Hepatitis A vaccine is indicated for immunization against infections caused by hepatitis A virus; Hepatitis B vaccine is indicated for immunization against infection caused by hepatitis B virus; and typhoid fever vaccine is indicated for active immunization against Salmonella typhi, the organism which causes typhoid fever.

Sponsors & Collaborators

• GlaxoSmithKline

  collaborator INDUSTRY

• MCM Vaccines B.V.

  collaborator INDUSTRY

• Canadian Center for Vaccinology

  collaborator OTHER

• Dalhousie University

  collaborator OTHER

• Canadian Immunization Research Network

  lead NETWORK

Principal Investigators

• Scott A Halperin, MD · Dalhousie

Study Design

Allocation

NA

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2017-02-15

Primary Completion

2021-07-05

Completion

2021-07-05

Countries

• Canada

Study Locations